1 insider has bought $144k of Surgery Partners, Inc. shares across 1 disclosed dealing since August 2026. 1 of those has been scored against our six-point signal check.
| Aug 18, 2026 | DeLuca Teresa — director | $143,500 |
Surgery Partners, Inc. is classed as health care. By value disclosed, that ranks 25th of the 45 health care companies where insiders bought in the last twelve months.
Companies with a comparable amount of disclosed buying: Medline Inc. · Larimar Therapeutics, Inc. · DENTSPLY SIRONA Inc. · NEONC TECHNOLOGIES HOLDINGS, INC. · Tonix Pharmaceuticals Holding Corp. · Annovis Bio, Inc.
See also the biggest buys, cluster buying and the most-active companies.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Every row is a public regulatory disclosure — a Form 4 filing with the SEC — collected within minutes of being published. We don’t take company submissions and we don’t edit the numbers; the only thing we add is the rating and the reasoning behind it.
Sometimes. A insider buying with their own money is one of the few honest signals in the market, but plenty of purchases are routine — small top-ups, scheme allocations, or a well-paid executive rounding out a holding. That’s what our six-point check is for: it separates the conviction buys from the housekeeping, and shows you which is which.
The pipeline runs every 15 minutes through the trading day, so a new disclosure appears here shortly after it’s filed. Company stats refresh daily.
Yes — that’s what the app is for. Follow Surgery Partners, Inc. and you’ll get a push the moment a insider files, with the full analysis attached, plus alerts if the price moves after a buy you’re following.
No. ddbx rates the conviction behind insider buys and shows the reasoning. It’s information, never a recommendation, and never a guarantee. What you do with it is your call.